OPTIMIZING PREGNANCY AND DELIVERY OUTCOMES IN WOMEN WITH ENDOCERVICITIS

Abstract

Endocervicitis, an inflammatory condition of the cervical canal, poses a
significant risk to reproductive health, particularly in pregnant women. The presence
of chronic inflammation can contribute to complications such as preterm labor,
premature rupture of membranes, and intrauterine infections, thereby adversely
affecting both maternal and neonatal outcomes. This paper reviews current
approaches to optimizing pregnancy and delivery outcomes in women diagnosed with
endocervicitis, emphasizing early diagnosis, effective antimicrobial and antiinflammatory
therapy, and the integration of preventive obstetric management. The
study highlights the importance of microbiological assessment, hormonal balance
correction, and immune modulation in treatment strategies. Additionally, modern
diagnostic tools—such as PCR-based pathogen identification and ultrasound
monitoring—play a critical role in personalized care. Evidence-based obstetric
interventions, including infection control, cervical surveillance, and targeted
antibiotic therapy, have been shown to improve delivery outcomes and reduce the risk
of postpartum complications. The integration of multidisciplinary approaches
involving obstetricians, microbiologists, and immunologists is essential to achieve
optimal maternal-fetal health in cases complicated by endocervicitis.